期刊文献+

Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective,randomized controlled trial

Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective,randomized controlled trial
原文传递
导出
摘要 Objective To compare the efficacy and toxicities of combining homoharringtonine(HHT)±daunorubicin(DNR)with all-transretinoic acid(ATRA)based therapy and DNR plus ATRA based therapy in newly diagnosed low/intermediate risk acute promyelocytic leukemia(APL).Methods A total of 96 newly diagnosed pa-
作者 王迎
机构地区 Leukemia Center
出处 《China Medical Abstracts(Internal Medicine)》 2016年第2期54-,共1页 中国医学文摘(内科学分册(英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部